CD8A and neoplasm: Using the paired scRNA-seq and scTCR-seq, they identified the CD8+ CAR-T cells, within timely increased relative frequency (IRF) clonotypes, highly expressed the gene signatures of T cell cytotoxicity and proliferation, suggesting their effective roles in anti-tumor responses.